HALO (Halozyme Corp) Earnings per share growth rate in current year

HALO (Halozyme Therapeutics) - company brandmark

Diversification through technology licensing to leading pharma behemoths mitigates risks, as evidenced by the volatility of annual earnings per share. The value of 108.10 serves as the baseline indicator for this trend. The reputation of Halozyme Therapeutics (HALO) as a creator of innovative drug delivery methods ensures high partner confidence. The business's resilience to economic cycles is guaranteed by stable demand for oncology therapies.

HALO (Halozyme) Earnings growth in current year history from 07/04/2022 to 11/18/2026

Analytical breakdowns and data insights for company Halozyme Corp (HALO)

- business market valuation indicators:
Summary company analysis:Halozyme Therapeutics HALO
Finished products of Halozyme Inc.

This metric calculates the year-over-year dynamics of net earnings per share, updating data daily to eliminate the time gap between quarterly reports. By analyzing the annual EPS growth indicator, an investor can see the impact of licensing payments from pharma behemoths and the efficiency of hiring leading biotechnologists on the real capitalization of Halozyme Therapeutics (HALO).

Key competitors

Earnings per share growth rate in current year BeiGene Corp (ONC)|RVMD (Revolution Medicines Inc) - Earnings growth in current year|Earnings per share growth rate in current year Ascentage Pharma Group AAPG|Earnings growth in current year CGON|Earnings growth in current year UroGen Pharma Ltd (URGN)|Earnings growth in current year BCAX (Bicara Corp)|Personalis Genomics (PSNL) - Earnings per share growth rate in current year|Erasca Oncology - Earnings growth in current year|DCTH: Earnings per share growth in current year|YMAB: Earnings growth in current year|Aura Bio (AURA) - Earnings growth in current year|CADL (Candel Therapeutics Inc.) - Earnings growth in current year|ARAY: Earnings per share increase in current year|Net earnings per share growth this year SLS (SELLAS Life Sciences Group, Inc.)|Net earnings per one share growth for the current year ACTU|Citius Oncology - Net earnings per share growth this year|Earnings per share increase in current year HURA|TARA: Net earnings per share growth this year|Earnings per share growth rate in current year Fate Pharma|Aadi Bioscience Inc (WHWK) - Earnings per share growth in current year|Earnings per share growth rate in current year TScan (TCRX)|Net earnings per share growth this year CSBR|xbiotech.com (XBIT) - Expected net earnings per share growth this year|Earnings per share growth in current year cel-sci.com (CVM)|OSTX - Earnings per share growth rate in current year|Radiopharm Theranostics - Net earnings per share growth this year|Earnings per share increase in current year ARTV|ANL - Earnings per share growth in current year|VERU - Earnings growth in current year|Tempest Therapeutics, Inc. (TPST) - Earnings per share growth in current year|XLO: Net earnings per one share growth for the current year|RENB (Renovaro Biosciences) - Earnings growth in current year|MURA: Earnings per share increase in current year|Net earnings per share growth this year KAPA (Kairos Pharma Ltd)|Net earnings per one share growth for the current year OKUR|CytoMed Therapeutics Limited - Net earnings per share growth this year|CRIS: Earnings per share growth this year|APLM - Earnings per share growth in current year|THAR - Earnings growth in current year|ADVB: Earnings growth in current year|Earnings per share growth this year GNPX|CLDI (Calidi Biotherapeutics, Inc.) - Earnings growth in current year|Earnings per share growth in current year SBFM|Earnings growth in current year XBIO|Net earnings per share growth this year Salarius Pharmaceuticals SLRX|Earnings growth in current year PPBT (Purple Biotech Ltd)|AONC - Net earnings per share growth this year|BGNE: Net earnings per share growth this year|Expected net earnings per share growth this year Checkpoint Therapeutics, Inc CKPT|ELEV: Earnings growth in current year|Earnings per share growth rate in current year iCAD Inc. (ICAD)|IKNA (Ikena) - Earnings growth in current year|Net earnings per share growth this year Notable Labs (NTBL)|Earnings growth in current year VIRX|Net earnings per share growth this year MorphoSys Corporation MOR|NAYA Biosciences - Net earnings per share growth this year|Net earnings per share change in current year Ascentage Pharma